Content by user

ISMP Releases 2018-2019 Targeted Medication Safety Best Practices

This week ISMP has launched an updated version of its Targeted Medication Safety Best Practices, which include two revised and three new  practices for 2018-19.

To download a copy, go to:

The purpose of the Targeted Medication Safety Best Practices for Hospitals is to identify, inspire, and mobilize widespread, national adoption of consensus-based best practices for specific medication safety issues that continue to cause fatal and harmful errors in patients, despite repeated warnings in ISMP publications.

New ISMP Educational Opportunities

ISMP wishes to announce two new educational opportunities for MSOS members:

  • Third Free ISMP Video Newsletter
    • ISMP has launched the third in a series of “video newsletters” being produced in partnership with the Temple University School of Pharmacy. The videos feature short interviews with nationally recognized experts on current medication safety issues, and provide a summary of top content from the biweekly ISMP Medication Safety Alert! newsletter. The third video, now available online, focuses on: Safe administration of concentrated insulin products; Errors due to confusing product labeling; Educating patients about safe medication practices.  To view the ISMP video newsletters for free, visit:
  •  new ISMP/OE Medication Safety Focused Just Culture Certification Course.
    • Effective error prevention depends on having a Just Culture. Outcome Engenuity (OE), in partnership with ISMP, will offer a Medication Safety Focused Just Culture Certification Course in 2018 on February 21-22 in Phoenix, AZ. The course will train healthcare providers to lead their organizations through a culture transformation, and also includes a yearlong subscription to the Just Culture Assessment Tool (JCAT). Individuals signing up with an ISMP discount code (ISMP2018) will receive $200 off the registration. For more information or to register, please visit:

ISMP Self Assessment Deadline Extended to February 28, 2018

ISMP is extending the deadline date for healthcare facilities to submit their findings for its new self assessment on high-alert medications from December 15, 2017 to February 28, 2018. Each section of the ISMP Medication Safety Self Assessment for High-Alert Medications can be completed and submitted to ISMP separately when ready. ISMP is extending the deadline to ensure that organizations have enough time to participate in the full assessment by evaluating all the categories of high-alert medications used in their facilities. To access the self assessment workbook, go to:

Your Input Needed for New Quick Survey Feature.

MSOS is adding a “Quick Survey” feature to our website next month. Members will be asked one new question of interest each month on the MSOS website, that will offer 3 to 5 multiple choice options. Participants will receive instant feedback of the survey results. We are reaching out to MSOS members to ask for ideas/topics for the one question surveys that would be of interest to them. Please submit your ideas as a multiple choice question with answers to Members will receive an announcement with each new survey that is posted to the website.


ISMP launches new high-alert medication safety self assessment tool

ISMP has introduced a new tool to help hospitals, long-term care facilities, and certain outpatient facilities evaluate their best practices related to high-alert medications, identify opportunities for improvement, and track their experiences over time. The ISMP Medication Safety Self Assessment® for High-Alert Medications focuses on general high-alert medications and 11 specific medication categories--including opioids, insulin, neuromuscular blocking agents, chemotherapy, and moderate and minimal sedation. Participants who submit assessment findings to ISMP anonymously via a secure internet portal by December 15, 2017 will be able to obtain their weighted scores so they can compare themselves to demographically similar organizations. Participation also can help organizations meet requirements for managing high-alert medications from regulatory and accrediting agencies, such as the Centers for Medicare & Medicaid Services and The Joint Commission. To access the self assessment workbook, go to:

Share with your Anesthesiology Department: Opioid Safety Symposium at ASA

Opioids are still among the most frequent high-alert medications to cause patient harm, and anesthesia providers are in a key position to support improved understanding of the risks associated with the use of opioids. An ISMP symposium on opioid safety is being held at the American Society of Anesthesiologists (ASA) meeting on October 22, 2017 in Boston, MA. Please encourage your anesthesiology department to attend--there will be discussion about current opioid medication safety challenges and the potential leadership role for anesthesiologists in error prevention. For more information or to register, go to: